The Weill Cornell Medicine Hematology and Medical Oncology (Hem/Onc) Fellowship is approved by the ACGME for 18 positions, and we consistently attract an outstanding group of fellows from a large national pool. This fully-accredited, three-year combined subspecialty program leads to board eligibility in both Medical Oncology and Hematology. Hem/Onc Fellows participate in a number of educational conferences throughout their training, including case conferences, divisional grand rounds, journal clubs, and institutional tumor boards including breast, genitourinary, gastrointestinal, thoracic, and gynecologic cancers. In addition, a fellow-oriented core course covers all aspects of benign hematology, hematologic malignancies, and neoplastic diseases. Early in their training, each fellow will be directly involved in the design and conduct of clinical trials, both within the institution and through the Cancer and Leukemia Group B (CALGB). Prestigious scholarships from prominent organizations have been awarded to our Fellowship students for their research activities. The conferring organizations include the Howard Hughes Medical Research Institute and the American Society of Hematology, among others.
Additionally, at Weill Cornell we offer an advanced training fellowship for Bone Marrow Transplantation and Cellular Therapy. Since 2017, this non-ACGME Fellowship has accepted one (1) fellow each year for specialized training in Bone Marrow Transplantation (BMT) and Immune Effector Cell Therapy (IEC).